To further assess the therapeutic effect of metformin, we performed a large cohort study on SFTS patients, demonstrating that metformin significantly reduced viremia and decreased SFTSV-related deaths among individuals with pre-existing diabetes, in contrast with the disadvantageous effect of insulin administration. This evidence concerns the gene INS and diabetes mellitus.